Treatment of Diabetic Nephropathy through Ayurveda

Validation of AIIA Protocol in the management of Diabetic Nephropathy

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016596

Enrollment

Registered

2018-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E132- Other specified diabetes mellituswith kidney complications

Interventions

Intervention1: Gokshuradi Guggulu, Haritakyadi Kwatha, Bhumyamali Churna, Gokshura Churna: 1 gm of Gokshuradi Guggulu, 40 ml of Haritakyadi Kwatha and a blend of 3 gms each of Bhumyamali Churna and G

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic patients having controlled blood glucose level upto FBS 130mg/dl, PPBS 180mg/dl (on medication), Hypertensive patients BP up to 140/90 mm of Hg, Urinary albumin between 30-300mg in 24 Hr. urine sample and GFR between 60-120ml/min/1.73m2

Exclusion criteria

Exclusion criteria: Uncontrolled diabetic patients if blood glucose level more than FBS 130 mg/dl, PPBS 180 mg/dl, Uncontrolled Hypertensive patients with BP more than 140/90 mm of Hg., Microalbuminuria originating due to other diseases except Diabetes Mellitus. Patients with other severe complications of Diabetes Mellitus, Serum creatinine more than 2.5 mg., Albumin >300mg/day, GFR

Design outcomes

Primary

Measure	Time frame
Improvement in GFR and MicroalbuminuriaTimepoint: Two Months	—

Secondary

Measure	Time frame
Improvement in QoLTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Manisha

All India Institute of Ayurveda, Sarita Vihar,

drvyasayu@yahoo.in7838957972

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026